Skip Navigation


NDT Advance Access originally published online on March 22, 2006
Nephrology Dialysis Transplantation 2006 21(7):1906-1914; doi:10.1093/ndt/gfl098
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
21/7/1906    most recent
gfl098v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Briese, S.
Right arrow Articles by Querfeld, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Briese, S.
Right arrow Articles by Querfeld, U.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org


Original Articles: Dialysis and Transplantation

Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease—impact of calcium and vitamin D therapy

Sonia Briese1, Sandra Wiesner1, Joachim C. Will2, Alexander Lembcke3, Bernd Opgen-Rhein2, Richard Nissel1, Klaus-Dieter Wernecke4, Judit Andreae1, Dieter Haffner1,5 and Uwe Querfeld1,5

1 Department of Pediatric Nephrology, 2 Department of Pediatric Cardiology, 3 Department of Radiology, 4 Department of Medical Biostatistics, Charité Universitätsmedizin and 5 Center for Cardiovascular Research, Charité Universitätsmedizin, Berlin, Germany

Correspondence and offprint requests to: Uwe Querfeld, MD, Department of Pediatric Nephrology, Charité Universitätsmedizin, Berlin, Augustenburger Platz 1, 13353 Berlin, Germany. Email: uwe.querfeld{at}charite.de

Background. Studies in patients with childhood-onset end-stage renal disease (ESRD) provide a diagnostic window to the evolution of cardiovascular disease (CVD) in this population. Hyperphosphataemia and renal osteodystrophy are particularly difficult to treat in paediatric patients, but there is only limited information regarding the effect of calcium-containing phosphate binders and vitamin D preparations on the development of CVD in the young.

Methods. We studied 40 adult patients (mean age 23.6 years) who developed ESRD at the age of 11.5± 4 years and 40 matched healthy control subjects. Nine patients were on dialysis and 31 had a functioning kidney transplant. Measurements included intima-media thickness (IMT) of the common carotid artery, electron beam computed tomography (EBCT) for the detection of coronary artery calcifications (CAC), echocardiography and post-ischaemic arterial blood flow by venous occlusion plethysmography. Patient characteristics, atherosclerotic risk factors and a complete account of prescribed medications were analysed for correlations with arterial and cardiac changes.

Results. The IMT was not significantly different in patients and controls; four patients (10%) had coronary calcifications on EBCT. Twenty-five patients (62.5%) had left ventricular hypertrophy. Patients had a 40% reduction of post-ischaemic arterial flow. Morphological alterations of the heart and arteries were significantly correlated with the duration of ESRD and dialysis time, and with the cumulative intake of calcium-containing phosphate binders and active vitamin D preparations. Functional changes (vascular reactivity) were correlated with duration of ESRD and non-traditional risk factors.

Conclusions. Young adults with ESRD since childhood have systemic CVD characterized by a decrease in arterial elasticity, the occurrence of CAC and changes in left ventricular morphology. Treatment with calcium-containing phosphate binders and active vitamin D preparations is independently associated in a dose-dependent manner with surrogate markers for CVD.

Keywords: atherosclerosis; calcium; calcifications; children; end-stage renal disease; vitamin D


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
R. C. Shroff, A. E. Donald, M. P. Hiorns, A. Watson, S. Feather, D. Milford, E. A. Ellins, C. Storry, D. Ridout, J. Deanfield, et al.
Mineral Metabolism and Vascular Damage in Children on Dialysis
J. Am. Soc. Nephrol., November 1, 2007; 18(11): 2996 - 3003.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Fournier, L. Harbouche, J. Mansour, and I. Shahapuni
Impact of calcium and vitamin D therapy on arterial and cardiac disease in young adults with childhood-onset end stage renal disease
Nephrol. Dial. Transplant., March 1, 2007; 22(3): 956 - 957.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.